Accreditation Information

Claim CME, MOC, or receive Certificate of Participation for CEU:

Step 1: Visit the Center for Learning.

Step 2: Login (upper right corner of page).

Step 3: Click START to begin the evaluation.

Step 4: Click preference of CME/MOC, AANP, or Certificate of Participation.  Note: If claiming MOC, confirm your ABIM Diplomate number and click to update if necessary.

Note: CME and AANP Credits as well as MOC Points should be claimed upon completion of the activity. The evaluation will open on September 12, 2020. Clinical Endocrinology Update is eligible for 27.95 AMA PRA Category 1 Credit(s)™ and ABIM MOC Points as well as 18.95 contact hours of continuing education (which includes 15.35 hours of pharmacology).

Claim CME and MOC credit or receive a Certificate of Participation for Ancillary Symposia:

Step 1: Click on the symposium you are seeking credit for:

New Horizons for Medical Management of Acromegaly
Hypophosphatemia: Unlocking the Key to Improved Diagnosis and Management
Keeping Sight of Thyroid Eye Disease

Step 2: Login (upper right corner of page).

Step 3: Click START to begin the evaluation.

The evaluations are available immediately at the end of each symposium.

Accreditation

The Endocrine Society is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The Endocrine Society has achieved Accreditation with Commendation. Faculty disclosures can be found on each session page.

Disclosures: Clinical Endocrinology Update Committee 2020 expandcollapse

Marc-Andre Cornier, MD – Chair

No relevant financial relationships.

Bradley D. Anawalt, MD

Other: Author of chapters for UpToDate

Serena Cardillo, MD

No relevant financial relationships.

Dana Z. Erickson, MD

No relevant financial relationships.

Monica Gadelha, MD, PhD

Advisory Board: Crinectics; Novartis

Research Investigator: Crinectics; Novartis

Speaker: Ipsen; Novartis

Tim Korevaar, MD, PhD

No relevant financial relationships.

Cecilia Low Wang, MD

Advisory Board: BioMarin Pharmaceutical Inc.; CSL Behring GMBH

Research Investigator: Novo Nordisk; uniQure

Other: Employee at CPC Clinical Research

Connie Newman, MD

No relevant financial relationships.

Elizabeth N. Pearce, MD, MSc

Other: Immediate Past President and member of Board of Directors at American Thyroid Association; Associate Editor of Journal at American Association of Clinical Endocrinologists; member of Management Council at Iodine Global Network

Micol Rothman, MD

No relevant financial relationships.

Learning Objectives

Upon completion of this virtual course, learners should be able to:

demonstrate updated knowledge of the pathophysiology, diagnosis, and treatment of diabetes, obesity, cardiovascular disease, dyslipidemia, as well as adrenal, metabolic, bone, pituitary, thyroid, and reproductive disorders;
practice updated clinical skills for more effective diagnosis, management, and treatment of endocrine disorders and related sequelae; and
apply updated knowledge and clinical skills in improving patient care.

Target Audience

This course is intended for physicians, fellows, and other healthcare professionals caring for individuals with or at risk of developing endocrine conditions.

CME Credit

The Endocrine Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Endocrine Society designates this live activity for a maximum of 28.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activities.

While offering CME credits noted above, this program is not intended to provide extensive training or certification in the field.

CE Credit

This activity is approved for 27.95 contact hours of continuing education (which includes 15.35 hours of pharmacology) by the American Association of Nurse Practitioners. Activity ID 20084443. This activity was planned in accordance with AANP Accreditation Standards and Policies.

Maintenance of Certification (MOC)

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 28.75 points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

European Accreditation Council for Continuing Medical Education

The European Accreditation Council for Continuing Medical Education (EACCME) and the American Medical Association (AMA) signed an agreement of mutual recognition of CME credits between Europe and the USA whereby:

European physicians attending an event in the USA had their credits recognized in Europe and American physicians attending an event in Europe had their credits recognized in the USA.

The Endocrine Society designates this educational activity for a maximum of 28.75 AMA PRA Category 1 Credit(s)™ for CEU 2020. Each medical specialist should claim only those credits that he/she actually spent in the educational activity. These credits can be converted by the EACCME into European CME credits and/or into National credits by the European National Authorities.

Royal College of Physicians and Surgeons of Canada

Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME's "CME in Support of MOC" program in Section 3 of the Royal College's MOC Program

Statement of Independence

As a provider of CME accredited by the Accreditation Council for Continuing Medical Education, the Endocrine Society has a policy of ensuring that the content and quality of this educational activity are balanced, independent, objective, and scientifically rigorous. The scientific content of this activity was developed under the supervision of the Endocrine Society’s guideline task force.

Disclosures Policy

The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion. The Endocrine Society has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.

Disclaimersexpandcollapse

Use of Professional Judgement: The educational content in this activity relates to basic principles of diagnosis and therapy and does not substitute for individual patient assessment based on the health care provider’s examination of the patient and consideration of laboratory data and other factors unique to the patient. Standards in medicine change as new data become available.

Drugs and Dosage: When prescribing medications, the physician is advised to check the product information sheet accompanying each drug to verify conditions of use and to identify any changes in drug dosage schedule or contraindications

Policy on Unlabeled/Off-Label Use: The Endocrine Society has determined that disclosure of unlabeled/off-label or investigational use of commercial product(s) is informative for audiences and therefore requires this information to be disclosed to the learners at the beginning of the presentation. Uses of specific therapeutic agents, devices, and other products discussed in this educational activity may not be the same as those indicated in product labeling approved by the Food and Drug Administration (FDA). The Endocrine Society requires that any discussions of such “off-label” use be based on scientific research that conforms to generally accepted standards of experimental design, data collection, and data analysis. Before recommending or prescribing any therapeutic agent or device, learners should review the complete prescribing information, including indications, contraindications, warnings, precautions, and adverse events

Privacy and Confidentiality Statement: The Endocrine Society will record learner’s personal information as provided on CME evaluations to allow for issuance and tracking of CME certificates. The Endocrine Society may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its CME program. No individual performance data or any other personal information collected from evaluations will be shared with third parties